http://www.theoneclickgroup.co.uk/news.php?start=3660&end=3680&view=yes&id=4926#newspost
Psychiatric drugs & suicide in Sweden 2007
A report based on data from the
National Board of Health and Welfare
By Janne Larsson
ONE CLICK EXTRACTS
The purpose of this investigation has been to find data about the preceding psychopharmacologic al treatment for all persons who committed suicide in Sweden 2007.
The conclusion is that a large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of and close to the suicide.
This is a report about suicides committed in Sweden (with around 9 million citizens) in 2007 and the psychiatric drug treatment that preceded these suicides.
The report has three main parts:
• It gives unique data about all suicides committed in 2007 and the psychiatric
drugs that the persons received within a year of the suicide.
• It compares these data with autopsy reports about psychiatric drugs found in
the blood (of 98%) of all the persons who committed suicide in 2007.
• It gives extensive information about the psychiatric drug treatment given
within a year to the subgroup of persons who committed suicide in 2007 and
then were reported to the National Board of Health and Welfare by reason of
law 3 - one third of all suicides committed that year.
The data presented on these pages should have been published by the responsible national authorities.
A large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of their suicide.
The idea that persons who are depressed are suffering from “chemical imbalances”nand are deficient in the substance serotonin has been marketed by the pharmaceutical companies selling antidepressants (in the class SSRI, such as Prozac, Paxil/Seroxat, Zoloft) for more than a decade. The intensive marketing has led persons to believe that their low mood is a deficiency disease – and that it is vital to supply the substance that corrects this deficiency – the antidepressant drug.
But there is no scientific evidence that a low mood is caused by a ”chemical imbalance” in the brain 10 11. The hypothesis has been rejected with the following words by one of the most well known names in the field: “The serotonin theory of depression is comparable to the masturbatory theory of insanity.” 12 (The old theory that masturbation caused insanity.)
The Swedish medical agencies and their psychiatric consultants have used old data from forensic toxicological screenings to mislead the public and to heavily increase the use of antidepressants and other psychiatric drugs.
The most important information in this area is the patients’ medical history, the treatment history. Antidepressants, neuroleptics and other psychiatric drugs may cause harmful changes in the brain and these brain dysfunctions do not vanish when the drugs are discontinued – in many cases they cause chronic dysfunction to the brain, exemplified by the known neurological harm caused by neuroleptics. Many patients also get serious withdrawal reactions; reactions that can be so severe that they can lead to suicide.
Better sources of information are the unpublished clinical trials of psychiatric drugs done by pharmaceutical companies, and the important studies done by independent researchers. A number of these studies show that antidepressants and neuroleptics increase the risk of suicidal behaviour and directly cause effects that lead to suicide.
Considering the results presented in this report, it is no longer possible to say that ”more” of the same sort is the solution to the problem. It’s not “more psychiatry” – more psychiatric drugs – that is the solution. Politicians, trying to surpass each other in demanding more funds for a psychiatric industry that only means more “treatment” with psychiatric drugs, should know that they directly contribute to harming people and to the creation of more “results” of the sort presented in this report. Subservient nodding and voting when psychiatric opinion leaders require changes in law, so that people can be drugged with force in their homes, and so that “drug treatment without exceptions” can be given for people with mental problems, only lead to an increase in the psychiatric results described earlier. This report clearly shows one thing: A large majority of persons committed suicide after having had “adequate drug treatment” – in the meaning used in psychiatry; the very treatment that should prevent suicide. There is no reason to believe that the reporting system for adverse drug events work better in other countries. The catastrophic state of these “surveillance systems” makes it possible to keep destructive drugs on the market year after year. All it takes
is for pharmaceutical companies to show that many persons have been exposed to these drugs, and that almost no adverse event reports have been submitted; the drugs must be “safe and effective”.
This example from Sweden shows that in 338 cases persons committed suicide after having been prescribed psychiatric drugs – and none of these cases were reported to the registry for adverse drug events. Instead of Eli Lilly claiming that the drug Zyprexa was involved in 0 cases of suicide in Sweden 2007, the fact was that the drug was involved in 52 cases in this subgroup of 338 persons. Instead of Wyeth claiming the same for Effexor, the fact was that the drug was involved in 41 cases in
this group.
The reporting system must be completely reformed right away. It must be made mandatory for health care professionals to directly report all suspected serious adverse drug effects, and persons not reporting must be disciplined. Patients must be fully informed about the actual harmful effects of the drugs and given the right to report these effects to the adverse events registry, with the promise of effective follow-up. The reformed system must not give room for the now ruling psychiatric concealment ideology, where obvious harmful effects of psychiatric drugs are treated as “symptoms” requiring more drugs. Instead all these effects must be reported as suspected harmful effects from the drugs. And, most importantly, the data presented in this report must lead to basic changes in the ways in which persons with mental problems are being cared for.
FULL TEXT
Psychiatric drugs & suicide in Sweden 2007
A report based on data from the
National Board of Health and Welfare
By Janne Larsson
http://www.theoneclickgroup.co.uk/news.php?start=3660&end=3680&view=yes&id=4926#newspost
Psychiatric drugs & suicide in Sweden 2007
A report based on data from the
National Board of Health and Welfare
By Janne Larsson
ONE CLICK EXTRACTS
The purpose of this investigation has been to find data about the preceding psychopharmacologic al treatment for all persons who committed suicide in Sweden 2007.
The conclusion is that a large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of and close to the suicide.
This is a report about suicides committed in Sweden (with around 9 million citizens) in 2007 and the psychiatric drug treatment that preceded these suicides.
The report has three main parts:
• It gives unique data about all suicides committed in 2007 and the psychiatric
drugs that the persons received within a year of the suicide.
• It compares these data with autopsy reports about psychiatric drugs found in
the blood (of 98%) of all the persons who committed suicide in 2007.
• It gives extensive information about the psychiatric drug treatment given
within a year to the subgroup of persons who committed suicide in 2007 and
then were reported to the National Board of Health and Welfare by reason of
law 3 - one third of all suicides committed that year.
The data presented on these pages should have been published by the responsible national authorities.
A large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of their suicide.
The idea that persons who are depressed are suffering from “chemical imbalances”nand are deficient in the substance serotonin has been marketed by the pharmaceutical companies selling antidepressants (in the class SSRI, such as Prozac, Paxil/Seroxat, Zoloft) for more than a decade. The intensive marketing has led persons to believe that their low mood is a deficiency disease – and that it is vital to supply the substance that corrects this deficiency – the antidepressant drug.
But there is no scientific evidence that a low mood is caused by a ”chemical imbalance” in the brain 10 11. The hypothesis has been rejected with the following words by one of the most well known names in the field: “The serotonin theory of depression is comparable to the masturbatory theory of insanity.” 12 (The old theory that masturbation caused insanity.)
The Swedish medical agencies and their psychiatric consultants have used old data from forensic toxicological screenings to mislead the public and to heavily increase the use of antidepressants and other psychiatric drugs.
The most important information in this area is the patients’ medical history, the treatment history. Antidepressants, neuroleptics and other psychiatric drugs may cause harmful changes in the brain and these brain dysfunctions do not vanish when the drugs are discontinued – in many cases they cause chronic dysfunction to the brain, exemplified by the known neurological harm caused by neuroleptics. Many patients also get serious withdrawal reactions; reactions that can be so severe that they can lead to suicide.
Better sources of information are the unpublished clinical trials of psychiatric drugs done by pharmaceutical companies, and the important studies done by independent researchers. A number of these studies show that antidepressants and neuroleptics increase the risk of suicidal behaviour and directly cause effects that lead to suicide.
Considering the results presented in this report, it is no longer possible to say that ”more” of the same sort is the solution to the problem. It’s not “more psychiatry” – more psychiatric drugs – that is the solution. Politicians, trying to surpass each other in demanding more funds for a psychiatric industry that only means more “treatment” with psychiatric drugs, should know that they directly contribute to harming people and to the creation of more “results” of the sort presented in this report. Subservient nodding and voting when psychiatric opinion leaders require changes in law, so that people can be drugged with force in their homes, and so that “drug treatment without exceptions” can be given for people with mental problems, only lead to an increase in the psychiatric results described earlier. This report clearly shows one thing: A large majority of persons committed suicide after having had “adequate drug treatment” – in the meaning used in psychiatry; the very treatment that should prevent suicide. There is no reason to believe that the reporting system for adverse drug events work better in other countries. The catastrophic state of these “surveillance systems” makes it possible to keep destructive drugs on the market year after year. All it takes
is for pharmaceutical companies to show that many persons have been exposed to these drugs, and that almost no adverse event reports have been submitted; the drugs must be “safe and effective”.
This example from Sweden shows that in 338 cases persons committed suicide after having been prescribed psychiatric drugs – and none of these cases were reported to the registry for adverse drug events. Instead of Eli Lilly claiming that the drug Zyprexa was involved in 0 cases of suicide in Sweden 2007, the fact was that the drug was involved in 52 cases in this subgroup of 338 persons. Instead of Wyeth claiming the same for Effexor, the fact was that the drug was involved in 41 cases in
this group.
The reporting system must be completely reformed right away. It must be made mandatory for health care professionals to directly report all suspected serious adverse drug effects, and persons not reporting must be disciplined. Patients must be fully informed about the actual harmful effects of the drugs and given the right to report these effects to the adverse events registry, with the promise of effective follow-up. The reformed system must not give room for the now ruling psychiatric concealment ideology, where obvious harmful effects of psychiatric drugs are treated as “symptoms” requiring more drugs. Instead all these effects must be reported as suspected harmful effects from the drugs. And, most importantly, the data presented in this report must lead to basic changes in the ways in which persons with mental problems are being cared for.
FULL TEXT
Psychiatric drugs & suicide in Sweden 2007
A report based on data from the
National Board of Health and Welfare
By Janne Larsson
http://www.theoneclickgroup.co.uk/news.php?start=3660&end=3680&view=yes&id=4926#newspost
